Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: Lack of inhibition by aspirin

British Journal of Haematology

Volumn 138, Issue 2, 2007, Pages 221-230

  Falcinelli, Emanuela ^a   Giannini, Silvia ^a   Boschetti, Enrico ^a   Gresele, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Aspirin; Bleeding time; Matrix metalloproteinase 2; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; GELATINASE A;

ADULT; ARTICLE; BIOASSAY; BLEEDING TIME; BLOOD SAMPLING; BLOOD VESSEL INJURY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DRUG EFFECT; DRUG INHIBITION; ENZYME BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOBLOTTING; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN INJURY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION; VENOUS BLOOD; ZYMOGRAPHY;

ADMINISTRATION, ORAL; ADULT; ASPIRIN; BLEEDING TIME; BLOOD PLATELETS; FEMALE; FIBRINOLYTIC AGENTS; FLOW CYTOMETRY; HEMORRHAGE; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34250817676     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06632.x     Document Type: Article

References (37)

1. Abrams, C.S., Ellison, N., Budzynski, A.Z. Shattil, S.J. (1990) Direct detection of activated platelets and platelet-derived microparticles in humans. Blood, 75, 128 138.
2. Capper, S.J., Verheijen, J., Smith, L., Sully, M., Visser, H. Hanemaaijer, R. (1999) Determination of gelatinase-A (MMP-2) activity using a novel immunocapture assay. Annals of the New York Academy of Sciences, 878, 487 490.
3. Ciferri, S., Emiliani, C., Guglielmini, G., Orlacchio, A., Nenci, G.G. Gresele, P. (2000) Platelets release their lysosomal content in vivo in humans upon activation. Thrombosis and Haemostasis, 83, 157 164.
4. Emiliani, C., Ciferri, S., Mencarelli, S., Mezzasoma, A.M., Momi, S., Orlacchio, A. Gresele, P. (2006) Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders. Platelets, 17, 20 29.
5. Falcinelli, E., Guglielmini, G., Torti, M. Gresele, P. (2005) Intraplatelet signalling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. Journal of Thrombosis and Haemostasis, 3, 2526 2535.
6. Farndale, R.W., Sixma, J.J., Barnes, M.J. de Groot, P.G. (2004) The role of collagen in thrombosis and hemostasis. Journal of Thrombosis and Haemostasis, 2, 561 573.
7. Fernandez-Patron, C., Martinez-Cuesta, M.A., Salas, E., Sawicki, G., Wozniak, M., Radomski, M.W. Davidge, S.T. (1999) Differential regulation of platelet aggregation by matrix metalloproteinase 9 and 2. Thrombosis and Haemostasis, 82, 1730 1735.
8. Galis, Z.S. Khatri, J.J. (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research, 90, 251 262.
9. Galt, S.W., Lindemann, S., Allen, L., Medd, D.J., Falk, J.M., McIntyre, T.M., Prescott, S.M., Kraiss, L.W., Zimmerman, G.A. Weyrich, A.S. (2002) Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circulation Research, 90, 1093 1099.
10. Gresele, P., Arnout, J., Coene, M.C., Deckmyn, H. Vermylen, J. (1986) Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonucleate cells. Biochemical and Biophysical Research Communications, 137, 334 342.
11. Gresele, P., Arnout, J., Deckmyn, H., Huybrechts, E., Pieters, G. Vermylen, J. (1987) Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Journal of Clinical Investigation, 80, 1435 1445.
12. Gresele, P., Guglielmini, G., De Angelis, M., Ciferri, S., Ciofetta, M., Falcinelli, E., Lalli, C., Ciabattoni, G., Davi, G. Bolli, G.B. (2003) Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. Journal of the American College of Cardiology, 41, 1013 1020.
13. Hermann, A., Rauch, B.H., Braun, M., Schror, K. Weber, A.A. (2001) Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets, 12, 74 82.
14. Kazes, I., Elalamy, I., Sraer, J.D., Hatmi, M. Nguyen, G. (2000) Platelet release of trimolecular complex components MT1-MMP/TIMP-2/MMP-2: involvement in MMP-2 activation and platelet aggregation. Blood, 96, 3064 3069.
15. Kleiner, D.E. Stetler-Stevenson, W.G. (1994) Quantitative zymography: detection of picograms quantities of gelatinases. Analytical Biochemistry, 218, 325 329.
16. Klinger, M.H. Jelkmann, W. (2001) Subcellular localization of thrombopoietin in human blood platelets and its release upon thrombin stimulation. British Journal of Haematology, 115, 421 427.
17. Kroll, M.H. Feng, S. (2005) Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal?. Expert Review of Cardiovascular Therapy, 3, 941 951.
18. Kyrle, P.A., Westwick, J., Scully, M.F., Kakkar, V.V. Lewis, G.P. (1987) Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man: effect of low dose of aspirin. Thrombosis and Haemostasis, 57, 62 66.
19. McEver, R.P. (1990) Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells, 16, 73 83.
20. McGregor, J.L., Brochier, J., Wild, F., Follea, G., Trzeciak, M.C., James, E., Dechavanne, M., McGregor, L. Clemetson, K.J. (1983) Monoclonal antibodies against platelet membrane glycoproteins. European Journal of Biochemistry, 131, 427 436.
21. Michelson, A.D., Barnard, M.R., Krueger, L.A., Frelinger, III. A.L. Furman, M.I. (2002) Flow cytometric analysis of platelet function. In : Platelets in Thrombotic and Non-thrombotic Disorders (ed. by P. Gresele, C. Page, V. Fuster J. Vermylen pp. 485 499. Cambridge University Press, Cambridge, UK.
22. Mielke, C.H., Kaneshiro, M.M., Maher, I.A., Weinwr, J.M. Rapaport, D.I. (1969) The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood, 34, 204 215.
23. Mody, M., Lazarus, A.H., Semple, J.W. Freedman, J. (1999) Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfusion Medicine, 9, 147 154.
24. Momi, S., Falcinelli, E., Libert, C. Gresele, P. (2004) Deficiency of matrix metalloproteinase-2 (MMP-2) protects mice against platelet-dependent thrombosis. Circulation, Suppl. 111, 229 (abstract).
25. Monea, S., Lehti, K., Keski-Oja, J. Mignatti, P. (2002) Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. Journal of Cellular Physiology, 192, 160 170.
26. Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M.A. Peskar, B.A. (1980) Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thrombosis Research, 17, 317 327.
27. Rauch, B.H., Bretschneider, E., Braun, M. Schror, K. (2002) Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2. Circulation Research, 90, 1122 1127.
28. Sang, Q.X., Jin, Y., Newcomer, R.G., Monroe, S.C., Fang, X., Hurst, D.R., Lee, S., Cao, Q. Schwartz, M.A. (2006) Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Current Topics in Medicinal Chemistry, 6, 289 316.
29. Sawicki, G., Salas, E., Murat, J., Miszta-Lane, H. Radomski, M.W. (1997) Release of gelatinase A during platelet activation mediates aggregation. Nature, 386, 616 619.
30. Sawicki, G., Sanders, E.J., Salas, E., Wozniak, M., Rodrigo, J. Radomski, M.W. (1998) Localization and translocation of MMP-2 during aggregation of human platelets. Thrombosis and Haemostasis, 80, 836 839.
31. Schulze, C.J., Wang, W., Suarez-Pinzon, W.L., Sawicka, J., Sawicki, G. Schulz, R. (2003) Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation, 107, 2487 2492.
32. Sedlmayr, P., Blaschitz, A., Wilders-Truschnig, M., Tiran, A. Dohr, G. (1995) Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scandinavian Journal of Immunology, 42, 209 214.
33. Undas, A., Brummel, K., Musial, J., Mann, K.G. Szczeklik, A. (2001a) Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood, 98, 2423 2431.
34. Undas, A., Brummel, K.E., Musial, J., Mann, K.G. Szczeklik, A. (2001b) Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation, 103, 2248 2253.
35. Vezza, R., Nenci, G.G. Gresele, P. (1995) Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Journal of Pharmacology and Experimental Therapeutics, 275, 1497 1505.
36. Weltermann, A., Wolzt, M., Petersmann, K., Czerni, C., Graselli, U., Lechner, K. Kyrle, P.A. (1999) Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1757 1760.
37. Zeng, B., Prasan, A., Fung, K.C., Solanki, V., Bruce, D., Freedman, S.B. Brieger, D. (2005) Elevated circulating levels of matrix metalloptroteinase-9 and -2 in patients with symptomatic coronary artery disease. Internal Medicine Journal, 35, 331 335.